Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007245.4(ATXN2L):c.49C>T(p.Pro17Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000747 in 1,339,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
ATXN2L (HGNC:31326): (ataxin 2 like) This gene encodes an ataxin type 2 related protein of unknown function. This protein is a member of the spinocerebellar ataxia (SCAs) family, which is associated with a complex group of neurodegenerative disorders. Several alternatively spliced transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.49C>T (p.P17S) alteration is located in exon 1 (coding exon 1) of the ATXN2L gene. This alteration results from a C to T substitution at nucleotide position 49, causing the proline (P) at amino acid position 17 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of catalytic residue at P17 (P = 0.0081);Loss of catalytic residue at P17 (P = 0.0081);Loss of catalytic residue at P17 (P = 0.0081);Loss of catalytic residue at P17 (P = 0.0081);Loss of catalytic residue at P17 (P = 0.0081);Loss of catalytic residue at P17 (P = 0.0081);Loss of catalytic residue at P17 (P = 0.0081);